The presence of a novel functional estrogen receptor on the human sperm surface has been demonstrated by using different experimental approaches. Ligand blot analysis of sperm lysates, using peroxidaseconjugated estradiol as probe, identified a specific estradiol-binding protein of approximately 29-kDa apparent molecular mass. The same protein band was also revealed by using ␣H222 antibody, which is directed against the steroid binding domain of the genomic estrogen receptor. The biological effects of estrogen receptor were investigated by analyzing calcium fluxes, tyrosine phosphorylation, and acrosome reaction (AR) in response to 17␤-estradiol (17␤E 2 ) and by measuring the steroid influence on calcium and AR in responses to progesterone (P), a well-known physiological stimulus for human spermatozoa. Our results demonstrate that 17␤E 2 induces a rapid and sustained increase of intracellular calcium concentrations ([Ca 2ϩ ] i ). This effect is totally dependent on the presence of extracellular calcium, because it is completely abolished in a calcium-depleted medium. The doseresponse curve for calcium increase to 17␤E 2 is biphasic with a first component in the nanomolar range (effective concentration 50 ϭ 0.60 Ϯ 0.12 nmol/L) and a second component in the micromolar range (EC 50 ϭ 3.80 Ϯ 0.26 mol/L). 17␤E 2 stimulates tyrosine phosphorylation of several sperm proteins, including the 29-kDa protein band, and determines a reduction of calcium response to P, finally resulting in inhibition of P-stimulated sperm AR. Conversely, no direct effect of 17␤E 2 is observed on AR. 17␤E 2 effects on calcium are clearly mediated by a membrane receptor, because they are reproduced by the membrane-impermeable conjugate of the hormone BSA-E 2 and reduced by sperm preincubation with ␣H222 antibody. Taken together, our results clearly show the presence of a functional surface estrogen receptor, of 29 kDa, on human spermatozoa. This receptor may play a role in the modulation of nongenomic action of P in these cells during the process of fertilization. (J Clin Endocrinol Metab 84: 1670 -1678, 1999) S EVERAL steroid hormones have been demonstrated to exert rapid effects on cells by interacting with specific receptors present on surface (1). In particular, estrogen has been described as affecting intracellular calcium concentrations ([Ca 2ϩ ] i ), cAMP levels, mitogen-activated protein kinase activity (2), phospholipase C (3) and A 2 (4), and protein kinase C (5) in different tissues and cell lines. Both progesterone (P) and estrogen are present at high levels in follicular fluid (6 -8). In particular, average estradiol concentrations in follicular fluid from mature oocyte are in the micromolar range (6 -8). Rapid effects of both estradiol and P have been extensively demonstrated in human oocytes, as well as their role in oocyte activation and development (for review, see Ref. 9). Although nongenomic effects of P on human spermatozoa have been well elucidated, showing that P stimulates a cascade of signaling pathways leading to induction of acrosome reaction (AR) (10) and functional P surface receptor have been recently characterized (11), little is known about the estrogen effects in these cells (for review, see Ref. 9). The influence exerted by the steroid depletion in estrogen receptor knock-out mice has been investigated recently on maturation of spermatozoa (12), showing reduced motility and absence of fertilizing potential. Moreover, several competitive binding (13, 14) and immunofluorescence (15) studies suggest the presence of specific binding sites for 17␤-estradiol (17␤E 2 ) on human sperm surface. However, although Cheng et al. (16) could not detect specific binding sites for 17␤E 2 in the sperm cytosolic and nuclear fractions, the effects exerted by this steroid on sperm motility and fertilization potential seem to be inhibited by the classical genomic receptor antagonist tamoxifen (17). Thus, at present, the nature of these receptors remains unclear.
response curve for calcium increase to 17␤E 2 is biphasic with a first component in the nanomolar range (effective concentration 50 ϭ 0.60 Ϯ 0.12 nmol/L) and a second component in the micromolar range (EC 50 ϭ 3.80 Ϯ 0.26 mol/L). 17␤E 2 stimulates tyrosine phosphorylation of several sperm proteins, including the 29-kDa protein band, and determines a reduction of calcium response to P, finally resulting in inhibition of P-stimulated sperm AR. Conversely, no direct effect of 17␤E 2 is observed on AR. 17␤E 2 effects on calcium are clearly mediated by a membrane receptor, because they are reproduced by the membrane-impermeable conjugate of the hormone BSA-E 2 and reduced by sperm preincubation with ␣H222 antibody. Taken together, our results clearly show the presence of a functional surface estrogen receptor, of 29 kDa, on human spermatozoa. This receptor may play a role in the modulation of nongenomic action of P in these cells during the process of fertilization. (J Clin Endocrinol Metab 84: 1670 -1678, 1999) S EVERAL steroid hormones have been demonstrated to exert rapid effects on cells by interacting with specific receptors present on surface (1) . In particular, estrogen has been described as affecting intracellular calcium concentrations ([Ca 2ϩ ] i ), cAMP levels, mitogen-activated protein kinase activity (2) , phospholipase C (3) and A 2 (4) , and protein kinase C (5) in different tissues and cell lines. Both progesterone (P) and estrogen are present at high levels in follicular fluid (6 -8) . In particular, average estradiol concentrations in follicular fluid from mature oocyte are in the micromolar range (6 -8) . Rapid effects of both estradiol and P have been extensively demonstrated in human oocytes, as well as their role in oocyte activation and development (for review, see Ref. 9) . Although nongenomic effects of P on human spermatozoa have been well elucidated, showing that P stimulates a cascade of signaling pathways leading to induction of acrosome reaction (AR) (10) and functional P surface receptor have been recently characterized (11) , little is known about the estrogen effects in these cells (for review, see Ref. 9) . The influence exerted by the steroid depletion in estrogen receptor knock-out mice has been investigated recently on maturation of spermatozoa (12) , showing reduced motility and absence of fertilizing potential. Moreover, several competitive binding (13, 14) and immunofluorescence (15) studies suggest the presence of specific binding sites for 17␤-estradiol (17␤E 2 ) on human sperm surface. However, although Cheng et al. (16) could not detect specific binding sites for 17␤E 2 in the sperm cytosolic and nuclear fractions, the effects exerted by this steroid on sperm motility and fertilization potential seem to be inhibited by the classical genomic receptor antagonist tamoxifen (17) . Thus, at present, the nature of these receptors remains unclear.
Interestingly, some interactions between P and estrogen at membrane level have been suggested both in spermatozoa and brain tissues. P competes with [ 3 H]17␤E 2 binding to intact human spermatozoa (18) , and estradiol can displace iodide P binding to a protein of 29 kDa identified on mouse brain membrane lysates (19, 20) .
In the present study, we report identification and partial characterization of a novel receptor for estrogen on human sperm membrane, using functional and biochemical approaches similar to those applied by our group to characterize the nongenomic receptor for P on human sperm surface (11) . We investigated the biological effects of 17␤E 2 on intracellular calcium levels in fura-2-loaded spermatozoa and on AR. In addition, we examined the possible interference exerted by this steroid on calcium and AR in response to P. Finally, by ligand and Western blot analysis of sperm lysates, we initiated the molecular characterization of estrogen receptor and investigated the modulation of tyrosine phosphorylation pattern of this protein in response to administration of the steroid.
Materials and Methods Chemicals
Percoll was obtained from Pharmacia LKB (Uppsala, Sweden). Human serum albumin-free human tubal fluid (HTF) was from Irvine (Santa Ana, CA). All free steroids, peroxidase-conjugated estradiol (E 2 -POD), 6-(O-carboxymethyl)oxime-estradiol conjugated with BSA (BSA-E 2 ), secondary conjugated antibodies, fluorescein isothiocyanate-labeled Arachis hypogea (peanut) lectin, and all the other chemicals were from Sigma Chemical Co. (St. Louis, MO). Reagents for SDS-PAGE and for protein measurement were from Bio-Rad Laboratories, Inc. (Hercules, CA). Monoclonal ␣H222 antibody was a kind gift of Prof. Geoffrey Greene (The Ben May Institute for Cancer Research, University of Chicago, Chicago, IL). Peroxidase-conjugated monoclonal (PY20-HRP) antiphosphotyrosine antibodies were from ICN (Costa Mesa, CA). Digitonin and Fura-2/AM were obtained from Calbiochem (La Jolla, CA). The BM enhanced-chemiluminescence system was from Boehringer (Mannheim, Germany).
Preparation of spermatozoa
Human semen was collected, according to the World Health Organization (WHO)-recommended procedure (21) by masturbation, from normozoospermic men undergoing semen analysis for couple infertility. Samples with a linear progressive motility of less than 50% and with leukocytes and/or immature germ cell concentration greater than 10 6 /mL were not included in the study. Semen samples were processed as previously described (22) . Briefly, spermatozoa were separated on 40 and 80% Percoll gradients, combined, washed in HTF medium containing 0.3% fatty acid free-BSA, and resuspended in the same medium at the indicated concentration. Alternatively, sperms were separated by swim-up collection, according to the WHO-recommended procedure (21) . Spermatozoa were capacitated for 2 h or otherwise indicated in 0.3% BSA-containing HTF and treated as indicated in each experiment.
Preparation of sperm membranes
Sperm membranes were prepared as previously described (11) . Briefly, spermatozoa were lysed in lysis buffer [20 mmol/L Tris (pH 7.4), 150 mmol/L NaCl, 0.25% Nonidet P40, 1 mmol/L Na 3 VO 4 , 1 mmol/L phenylmethanesulfonyl flouride] for 1 h on ice. Then the samples were subjected to two subsequent cycles of homogenizing (teflon-glass) and sonicating 3 ϫ 15-sec 8 burst. The homogenates were centrifuged at 1,500 rpm for 10 min at 4 C, and supernatants were ultracentrifuged at 48,000 rpm for 45 min at 4 C. The resulting pellets (cellular membranes) were resuspended in lysis buffer and homogenized.
Preparation of uterine and myometrial cell lysates
Human uterine samples in the proliferative phase of the menstrual cycles, obtained at surgery, were processed as previously described (23) .
Myometrial cells, obtained as previously described (23), were resuspended in lysis buffer (see above). After protein measurement (Biorad kit, Bio-Rad Laboratories, Inc.), aliquots of cell extracts were applied onto SDS-polyacrylamide gels.
Measurement of intracellular calcium concentration
Spermatozoa, prepared as described above, were loaded with 2 mol/L Fura-2/AM for 45 min at 37 C, washed, resuspended in FM medium (125 mmol/L NaCl, 10 mmol/L KCl, 2.5 mmol/L CaCl 2 , 0.25 mmol/L MgCl 2 , 19 mmol/L Na-lactate, 2.5 mmol/L Na-pyruvate, 2 mmol/L HEPES, 0.3% BSA, pH 7.5), and [Ca 2ϩ ] i , before and after stimulation with the different agonists, was measured (as described previously) using a spectrofluorimetric method (22) 
SDS-PAGE
After the different incubations, as indicated, samples were processed for SDS-PAGE as previously described (25) . Briefly, sperm samples containing 10 7 cells/mL were added with 1 mmol/L Na 3 VO 4 , centrifuged at 400 ϫ g at 4 C for 10 min, washed in PBS, and resuspended in 20 L lysis buffer. After protein measurement (Biorad kit, Bio-Rad Laboratories, Inc.), the sperm extracts, containing the same protein amount, were diluted in an equal volume of reducing 2ϫ loading buffer (1ϫ ϭ 62.5 mmol/L Tris (pH 6.8), 10% glycerol, 20% SDS, 2.5% pyronin, and 100 mmol/L dithiotheitrol), incubated at 95 C for 5 min, and loaded onto 10% polyacrylamide-bisacrylamide midi-and minigels. After SDS-PAGE, proteins were transferred to nitrocellulose membranes.
Ligand blot analysis
Nitrocelluloses filters with transferred proteins were treated for ligand blot analysis of sperm proteins, as previously described (11) 
Western blot analysis
Nitrocelluloses filters with transferred proteins were blocked overnight at 4 C in TTBS (0.1% Tween-20, 20 mmol/L Tris, 150 mmol/L NaCl) containing 5% BSA, then washed repeatedly in TTBS, and incubated for 2 h in 2% BSA-TTBS containing PY20-HRP antibody (1:1000). After several washes in TTBS, reacted proteins were revealed by a BM chemiluminescence system. In some experiments, blots were washed for 30 min at 50 C in stripping buffer (10 mmol/L Tris (pH 6.8), 1% SDS, 5 mmol/L ␤-mercaptoethanol), to remove bound antiphosphotyrosine antibodies, then immunostaining was performed by 3-h incubation with ␣H222 antibody (1:400 in 2% BSA-TTBS), followed by 1-h incubation with antirat IgG-POD (1:4800 in 2% BSA-TTBS). Finally, the bands were visualized by the BM system. The immunospecificity of PY20 was determined by preadsorbing the antibody with 40 mmol/L o-phosphodl-tyrosine for 1 h at room temperature.
AR assay
Acrosome-reacted spermatozoa were evaluated using the fluorescent probe fluorescein isothiocyanate-labeled Arachis hypogea (peanut) lectin, according to Aitken et al. (26) , as previously described (27) . Briefly, after 2-h capacitation, spermatozoa (10 6 /mL) were preincubated for 10 min with 17␤E 2 at different concentrations and then stimulated with P (10 mol/L), or appropriate control solvent (dimethyl sulfoxide) for 2 h at 37 C. After staining with fluorescent lectin, fluorescence was observed under a fluorescent microscope (Leitz, Type 307-148.002, Wetzlar, Germany), and AR was evaluated on a total of 100 spermatozoa/slide. According to Aitken et al. (26) , only curly-tailed spermatozoa were considered viable and thus scored.
Analysis of experimental results
The computer program ALLFIT (28) was used for the analysis of sigmoidal dose-response curves obtained in calcium studies. Data are expressed as mean Ϯ sem. Statistical analysis was made with Student's t test and one-way ANOVA.
Results

Effects of estradiol on intracellular calcium concentrations in human spermatozoa
Addition of 17␤E 2 to fura-loaded spermatozoa induced a rapid and sustained rise of [Ca 2ϩ ] i in a dose-dependent manner. Figure 1 reports the typical calcium waves in response to increasing concentrations of 17␤E 2 (0.1 nmol/ L-100 mol/L). The dose-response curve for the calcium effect of 17␤E 2 , as generated by the simultaneous computer analysis with the program ALLFIT (28) , is biphasic (Fig. 2) , showing a first component with an effective concentration 50 of 0.60 Ϯ 0.12 nmol/L and a second component with an EC 50 of 3.80 Ϯ 0.26 mol/L. Also, because P stimulates a rapid calcium influx in human spermatozoa with a similar biphasic dose-response curve (11) , and interactions between P and estrogen have been reported (19, 20) , we tested the hypothesis of an eventual interference between the effects of the two steroids. Interestingly, the shapes of P-and 17␤E 2 -induced calcium waves were different: P induced first a rapid peak, followed by a long sustained plateau, whereas 17␤E 2 induced a slow sustained response (Fig. 1) . The typical [Ca 2ϩ ] i transient in response to P (10 mol/L) was reduced in a dose-dependent manner by a previous administration of 17␤E 2 , both in the peak and plateau components (Fig. 1 , also see Table  1 ). Table 1 reports the percentage peak and plateau [Ca 2ϩ ] i increases in response to P (10 mol/L) alone or after previous administration of increasing concentrations of 17␤E 2 . Inhibition of the plateau phase was statistically significant for all the tested doses of estradiol, whereas peak inhibition was statistically significant only for high concentrations ( Table 1 ). The effect of 17␤E 2 was specific for P-response, because the steroid did not affect [Ca 2ϩ ] i increase obtained after stimulation with the endoplasmic Ca 2ϩ -ATPase inhibitor thapsigargin (10 mol/L, Fig. 3 ), previously shown to increase calcium levels (29, 30) and AR (31) in human spermatozoa. Effects of 17␤E 2 , both on calcium levels and on calcium response to P, were not antagonized by the cytosolic estrogen receptor antagonist tamoxifen (not shown), suggesting that the classical estrogen receptors are not involved. The effect of 17␤E 2 seemed to be specific, because comparable concentrations of 17␣-estradiol (17␣E 2 ), even at 10 mol/L concentration, neither stimulated [Ca 2ϩ ] i rise nor interfered with P-induced response (Fig. 4 ). To further demonstrate that the effect of 17␤E 2 on [Ca 2ϩ ] i was mediated by a receptor present on sperm membrane, we used the membraneimpermeable estradiol conjugate BSA-E 2 . This compound induced an [Ca 2ϩ ] i increase similar to that of 17␤E 2 ( Fig.  5) , whereas the addition of BSA alone, the macromolecular component of the conjugate, was ineffective (not shown). BSA-E 2 was also able to mimic the inhibitory effect exerted by the free steroid on P-induced calcium waves (Fig. 5) . The biological effects of BSA-E 2 were observed until 0.1 mol/L concentration was achieved, which elicited an increase of basal [Ca 2ϩ ] i of about 1.16-fold (data not shown). Taken together, all these data demonstrate that 17␤E 2 acts through interaction with a surface receptor. The increase in [Ca 2ϩ ] i after addition of 17␤E 2 was totally dependent on the presence of extracellular calcium, because the response was absent when spermatozoa was stimulated in calcium-depleted medium in the presence of 2 mmol/L EGTA, and it was restored by subsequent replacement of external calcium to normal levels (Fig. 6B) . Similarly, the calcium wave induced by BSA-E 2 (1 mol/L) was blunted in the absence of extracellular calcium and was restored when [Ca 2ϩ ] e was replaced (Fig.  6C) . 
Effects of estradiol on AR
Because a [Ca 2ϩ ] i rise, induced by P, leads to an increase in AR of human spermatozoa, we next investigated whether 17␤E 2 effects on calcium were also involved in regulation of AR. As shown in Fig. 7 , 2-h incubation of capacitated spermatozoa with increasing concentrations of 17␤E 2 induced only a slight stimulation of AR at the highest dose used (10 mol/L). Interestingly, all the three doses of 17␤E 2 blunted AR in response to P (Fig. 7) .
Identification of estradiol receptor by ligand and Western blot analysis of human sperm lysates
To characterize 17␤E 2 -binding proteins in human spermatozoa, we performed, on total sperm lysates, ligand blot experiments using E 2 -POD as probe, and Western analysis with the monoclonal antibody ␣H222, directed against the steroid-binding domain of the genomic receptor (32). E 2 -POD has been shown to bind to a membrane estrogen receptor in pancreatic islet cells (33) , indicating that such molecule is a good tool to investigate this type of receptor. ␣H222 antibody has been shown to recognize a membrane estrogen receptor in rat pituitary tumor cells (34) . Moreover, the approach of using an antibody produced against the steroid binding sequence of the genomic receptor was applied by our (11) and other groups (35, 36) to identify the putative membrane receptors for P in human spermatozoa. In addition, preincubation of sperm samples with ␣H222 antibody (1:20, Fig. 8B ), but not with normal rat serum (1:20, Fig. 8C ), reduced 17␤E 2 stimulation of calcium influx (Fig. 8A) , suggesting that the sperm membrane receptor for estradiol is recognized by this antibody. A single band, of approximately 29-kDa molecular mass, is revealed both by E 2 -POD (0.5 mol/L, Fig. 9A ) and ␣H222 antibody (1:400, Fig. 9B ). An estrogen-binding protein of similar molecular mass has been described also in other cell types (19, 20, 37) . The same pro- tein band of 29 kDa was detected on purified sperm membranes stained with ␣H222 antibody (Fig. 9D) . Longer exposures of the ␣H222-stained blots revealed the presence of two additional bands, of about 42-45 kDa and 54 -58 kDa (Fig. 9E) . A protein band, at the expected 54 -58 kDa molecular mass range, probably corresponding to one of the known isoforms of the genomic estrogen receptor (38, 39) , was detected by ␣H222 both on myometrial cell and total uterus lysates, used as control for genomic estrogen receptors (Fig. 10) . Interestingly, myometrial cells also show the presence of a 29-kDa protein band (Fig. 10) .
Because phosphorylation of estrogen genomic receptor has been described as one of the mechanisms of receptor transactivation (40, 41), we investigated whether p29 was phosphorylated in tyrosine in human spermatozoa. Reprobing the blots shown in Fig. 9 , A and B, with PY20 antibody revealed that this protein was phosphorylated on tyrosine residues (Fig. 9C) . Moreover, a rapid (10 min) stimulation of capacitated spermatozoa with 17␤E 2 induced an increase of phosphorylation in tyrosine residues of several protein bands, including the p29 kDa one (Fig. 11A) . A comigration between this tyrosine phosphorylated band (Fig. 11A ) and the putative estrogen receptor was observed when the blot was washed thoroughly and reprobed with ␣H222 antibody (Fig. 11B ).
Discussion
Our paper demonstrates the presence of a functional estrogen receptor on human sperm surface. This receptor apparently is involved in the activation of two different signal transduction pathways, namely an increase of [Ca 2ϩ ] i and of tyrosine phosphorylation of proteins, resulting in inhibition of P-stimulated calcium influx and AR. Ligand and Western analyses of sperm lysates, using E 2 -POD and ␣H222 antibody as probes, reveal the presence of a protein band with an apparent molecular mass of 29 kDa. Location of this receptor on sperm surface is demonstrated both by the ability of the impermeable conjugate E 2 -BSA to induce similar calcium waves, as 17␤E 2 , as well as by the detection of the 29-kDa protein band in purified sperm membranes by Western analysis. The possible involvement of such a protein in the biological effects of 17␤E 2 is suggested by the inhibition of lecular mass of about 29 kDa, identified by photoaffinity labeling with progesterone-11␣-hemisuccinate-(2-[ 125 I)iodohistamine), and specifically displaced by incubation with estradiol, has been detected in mouse brain membranes (19, 20) and has been suggested as the putative membrane binding site for estrogen (20) . Moreover, Monje and Boland (37), using monoclonal antibodies against different domains of the intracellular estrogen receptor, identified on uterine membranes a 28-to 32-kDa protein, besides the expected 65-kDa band representing one of the genomic receptors. Such molecular mass (29 kDa) is quite different from the known classical ␣ and ␤ estrogen receptors (38, 39) . Higher exposures of films in our Western blot analysis of sperm lysates reveal that ␣H222 antibody faintly detects two additional sperm protein bands, the higher of which shows a molecular weight similar to one of the classical genomic receptors. Although we have used all the necessary precautions to minimize eventual protein cleavage, the possibility that the 29-kDa protein band is a proteolytic fragment of the fulllength estrogen receptor cannot be excluded. Also, it possible that a specific regulatory protein cleavage is involved in synthesis of the functional estrogen receptor in spermatozoa. The fact that other bands are seen with ␣H222 antibody suggests this possibility. On the other hand, a 66-kDa estrogen receptor that comigrates with a similar protein in the endometrial tissue has been detected, with a different antibody in human spermatozoa, by Durkee et al. (15) . However, these authors could not discriminate whether this form represented the genomic receptor or not. Interestingly, the same authors detected, by RT-PCR analysis of sperm RNA, two different amplified nucleotidic bands (15) , suggesting the presence of different messenger RNAs for estrogen receptors in human spermatozoa, as also described in other cell types (43, 44) . So far, the question of whether classical genomic estrogen receptors are present in human spermatozoa still remains open. On the other hand, it is unlikely that the genomic estrogen receptor, if present, could be functional, because mature spermatozoa are transcriptionally silent. Moreover, our experiments clearly show that the 29-kDa protein band is the only one detected by both ligand and Western blot analyses, strongly indicating that this protein represents the membrane receptor for estrogen in human spermatozoa.
The rapid increase of [Ca 2ϩ ] i and phosphorylation induced by 17␤E 2 in human spermatozoa confirms the findings in other cell types for nongenomic/rapid actions of estrogens (37, (45) (46) (47) (48) (49) . As in the case of P (50), both 17␤E 2 -and BSA-E 2 -stimulated [Ca 2ϩ ] i increases in spermatozoa are strictly dependent on the presence of extracellular calcium. Because this steroid is present in the follicular fluid (6 -8) and in the male genital tract (12) at concentrations similar to those inducing the biological effects observed in vitro in human sper- matozoa, it is conceivable that these effects may be physiologically relevant. The increase of calcium and tyrosine phosphorylation of proteins stimulated by 17␤E 2 in human spermatozoa is not followed by induction of AR; rather, these effects interfere with those exerted by P. Indeed, a previous addition of 17␤E 2 inhibits, in a dose-dependent manner, the subsequent calcium and AR responses to P. In particular, the plateau phase of P calcium response is significantly reduced after a first priming with very low concentrations of 17␤E 2 . Because the plateau phase of P-induced [Ca 2ϩ ] i increase has been associated with induction of AR (50), it is conceivable that inhibition of P-stimulated AR by 17␤E 2 is attributable to inhibition of the plateau phase. Stimulation of tyrosine phosphorylation of its own receptor may be involved in the modulation of receptor binding activity. Indeed, modulation of the phosphorylation state of the estrogen receptor by the steroid itself or other substances has been associated with transactivation of the classical genomic estrogen receptor (40, 41) . In particular, tyrosine phosphorylation occurs in the ligand binding domain of the genomic receptor (52) .
The precise mechanism involved in 17␤E 2 inhibition of calcium and AR response to P in human spermatozoa is still unclear. Other groups reported rapid inhibitory effects of 17␤E 2 on vascular smooth muscle contraction (53-56) and on neuron hyperpolarization (57) . In particular, the rapid inhibitions of coronary artery contraction [either basal (56) or induced by PG F 2␣ , extracellular potassium (54), and endothelin (55)] seem to be mediated by reduction of cellular calcium influx via blockage of L-type Ca 2ϩ channels (53). Lagrange et al. (57) reported 17␤E 2 reduction of -opioids' ability to hyperpolarize guinea pig hypotalamic neurons via G protein-coupled receptors. However, in all these cases, the inhibitory effects of 17␤E 2 are never associated with an increase of calcium influx induced by the steroid itself, as in our experiments. It is possible that the partial stimulation by 17␤E 2 of the same signal transduction pathways of P interferes with the biological response to the latter, leading to inhibition of AR. However, the possibility that 17␤E 2 and P compete for the same receptors cannot be excluded.
Interestingly, the sperm calcium curve, in response to 17␤E 2 , shows a biphasic behavior, with two components (one in the nanomolar and the other in the micromolar range), similar to the calcium curve obtained for P (11) . Although this result may suggest the presence of two different binding sites for estradiol, we have constantly observed the presence of a single 29-kDa protein band in ligand blot experiments with E 2 -POD. On the other hand, binding of 3 H-17␤E 2 to intact human spermatozoa revealed the presence of a single binding site, with a an apparent K d of 0.6 nmol/L (13), consistent with the first component of our curve. Similarly, the effect of 17␤E 2 on P-induced AR and plateau phase of calcium increases was observed at nanomolar concentrations.
Inhibition of rapid responses to 17␤E 2 by tamoxifen is controversial (45, 49, 58) . Indeed, whereas Lantin-Hermoso et al. (58) described a complete inhibition by tamoxifen on estradiol acute stimulation of nitric oxide synthase activity in artery endothelium, Watters et al. (49) found no effect of tamoxifen on rapid membrane effects of estrogen in neuroblastoma cells. Moreover, Morley et al. (45) showed that tamoxifen could not affect the rapid estrogen-triggered [Ca 2ϩ ] i increase in chicken granulosa cells. In our hands, this cytosolic estrogen receptor antagonist was ineffective in counteracting estradiol action on intracellular calcium, further suggesting that the estrogen receptor in spermatozoa differs from the genomic one.
In conclusion, our results demonstrate the presence of a biologically active sperm receptor for estrogen in human spermatozoa, suggesting a novel role for estradiol, in the process of fertilization, as a possible physiological modulator of P action on spermatozoa. Because levels of estradiol in the follicular fluid are similar to those inducing the observed nongenomic effects, the strict cross-talk between sperm membrane receptors for 17␤E 2 and P may be important for an appropriate timing of capacitation and AR in the female genital tract. Further studies are required to elucidate whether environmental chemicals with estrogen action might have similar effects on human sperm and to evaluate whether the absence of sperm response to P in several cases of idiopathic male infertility (27, 59 ) may be attributable to alteration in the interactions between these two steroids.
